MedCity News December 7, 2022
Katie Adams

Ekso Bionics — a company that makes exoskeleton bionic devices — recently acquired Parker Hannifin’s business unit for human motion and control for $10 million. The acquisition will help extend Ekso’s product line across the continuum of care and provides access to Vanderbilt University as a research partner.

Ekso Bionics — a San Rafael, California-based company that makes exoskeleton bionic devices — on Monday acquired Parker Hannifin’s business unit for human motion and control for $10 million. Parker is an Ohio-based manufacturer specializing in motion and control technologies. It received $5 million from Ekso at the deal’s closing, and it will receive the remaining $5 million over the next five years.

The acquisition will help extend Ekso’s product line across...

Today's Sponsors

Transcarent
SalesSparx

Today's Sponsor

Health Edge

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
How GE HealthCare Technologies Is Shaping Up for 2023
A new generation of microimplants
Council On Health Care Spending And Value: A Road Map For Action
Why there is no need for SMEs to turn to the US to launch their innovations
These blood-clot catching devices have been controversial for years. Why are doctors still relying on them?

Share This Article